What We’re Reading: J&J, Novavax Release COVID-19 Vaccine Data; Undercounted Nursing Home Deaths; Experts Encourage Double Masking
Johnson & Johnson, Novavax, release positive results from phase 3 trials on their respective coronavirus disease 2019 (COVID-19) vaccines; report indicates undercounted nursing home deaths in New York; experts push for improved mask practices.
J&J, Novavax Announce COVID-19 Vaccine Data
Both
Report Finds New York Nursing Homes Undercounted Deaths
According to a new state attorney general’s
Experts Encourage Improved Mask Practices
In light of new highly transmissible variants of COVID-19 spreading around the globe, experts are pushing for the public to either wear 2 masks or upgrade the quality of single masks to curb transmission, The Washington Post
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025